Listing ID #5634354
Company Information
Ask for more detail from the seller
Contact SupplierAbiraterone Is A CYP3A4 Substrate And Hence Should Not Be Administered In Patients Concurrently On Strong CYP3A4 Inhibitors Or Inducers.Likewise It Inhibits CYP1A2, CYP2C9 And CYP3A4 And Hence Should Not Be Given To Patients Concurrently Being Treated With Substrates Of Any Of These Enzymes That Have A Narrow Therapeutic Index.